Skip to main content

Table 3 Analysis of interaction between rs3740535 genotypes and family history of cancer

From: Relationship between cancer stem cell-related SNPs and survival outcomes in patients with primary lung cancer

Implicit model

Additive model

Genotype

Family history of cancer

αHR (95%CI)*

Genotype

Family history of cancer

αHR (95%CI)*

AG + GG

No

1

AA

No

1

AG + GG

Other tumors

0.969(0.761–1.234)

AA

Other tumors

0.906(0.678–1.210)

AG + GG

Lung cancer

1.129(0.810–1.572)

AA

Lung cancer

1.179(0.752–1.847)

AA

No

0.949(0.669–1.346)

GG

No

1.009(0.706–1.443)

AA

Other tumors

0.677(0.347–1.321)

GG

Other tumors

0.704(0.358–1.385)

AA

Lung cancer

2.047(0.744–5.637)

GG

Lung cancer

2.130(0.758–5.981)

Multiplication interaction

 

1.035(0.912–1.175)

Multiplication interaction

 

1.019(0.873–1.190)

Relative excess risk (RERI)

 

0.125(− 0.434–0.685)

Relative excess risk (RERI)

 

0.121(− 0.434–0.675)

Attributable risk percent (ARP)

 

0.203(− 0.594–1.001)

Attributable risk percent (ARP)

 

0.207(− 0.692–1.106)

Synergic index (S)

 

0.754(0.172–3.307)

Synergic index (S)

 

0.775(0.205–2.931)

  1. Note: * is adjusted for gender, age, first diagnosed metastasis, pleural metastasis, lymphatic metastasis, hematologic metastasis, BMI, whether there is treatment, whether there is surgery, a maximum diameter of tumor, whether there is a lung disease, education background, smoking history, and clinical stages (when adjusting factors are included, the corresponding combined items are not included in the adjustment)